Osteopore Limited (ASX:OSX)
Australia · Delayed Price · Currency is AUD 0.0090
-0.0010 (-10.00%)
Feb 11, 2026, 1:42 PM AEST
Osteopore Market Cap
Osteopore has a market cap or net worth of 4.33 million as of February 10, 2026. Its market cap has increased by 5.80% in one year.
Market Cap
4.33M
Enterprise Value
4.19M
Revenue
2.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since September 23, 2019, Osteopore's market cap has decreased from 73.39M to 4.33M, a decrease of -94.11%. That is a compound annual growth rate of -35.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 4.33M | 144.18% |
| Dec 31, 2025 | 1.77M | -56.67% |
| Dec 30, 2024 | 4.09M | -40.03% |
| Dec 29, 2023 | 6.82M | -61.25% |
| Dec 30, 2022 | 17.59M | -33.33% |
| Dec 31, 2021 | 26.39M | -56.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.95B |
| Sigma Healthcare | 35.88B |
| Pro Medicus | 16.84B |
| Cochlear | 16.55B |
| Genetic Technologies | 5.67M |
| BPH Global | 5.56M |
| Nexalis Therapeutics | 5.42M |
| Argent BioPharma | 4.56M |